VP
venBio Partners Portfolio holdings
AUM
$115M
This Quarter Return
-30.28%
1 Year Return
-33.99%
3 Year Return
+221.07%
5 Year Return
+224.54%
10 Year Return
–
AUM
$38.1M
AUM Growth
+$38.1M
(-33%)
Cap. Flow
-$8.22M
Cap. Flow
% of AUM
-21.58%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
4
New
1
Increased
–
Reduced
–
Closed
1
Top Buys
| 1 |
Apellis Pharmaceuticals
APLS
|
$23.6M |
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Apellis Pharmaceuticals
APLS
$3.48B
| $23.6M | 62.01% | +1,790,102 | New | +$23.6M |
|
|
VRNA
2
Verona Pharma
VRNA
$9.16B
| $8.44M | 22.18% | 875,000 | – | – |
|
3
VYNE Therapeutics
VYNE
$8.16M
| $6.02M | 15.82% | 1,461,552 | – | – |
|